Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion type Assertion NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_head.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion description "[Although corticotropin-releasing hormone (CRH) and Fas ligand (FasL) have been documented in ovarian carcinoma, a clear association with tumour progression and immuno-escape has not been established.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_provenance.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion evidence source_evidence_literature NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_provenance.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion SIO_000772 17667919 NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_provenance.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion wasDerivedFrom befree-2016 NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_provenance.
- NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_assertion wasGeneratedBy ECO_0000203 NP622786.RAPkAGkzHbSp5jePMiV0_EJt01zLOVutOxeD_SaPKwmCc130_provenance.